Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7VA3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,669
Award facts
- Contract value 100% obligated
- $16,669.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,669.12 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This firm fixed-price contract, awarded on January 9, 2026, with an ultimate completion date of January 12, 2026, represents a routine pharmaceutical procurement under a non-set-aside competition. The contractor is headquartered in Conshohocken, Pennsylvania, with the place of performance also located in Conshohocken. This delivery order falls under AmerisourceBergen's broader federal pharmaceutical supply network, which serves critical military and veteran healthcare requirements.
This award is a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent company, Cencora, Inc. (which operates as AmerisourceBergen), holds a substantial IDC with the DLA valued at up to $999,999,999.00 through December 31, 2031. Through these comprehensive contract vehicles, AmerisourceBergen supplies a wide range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military treatment facilities and veterans' healthcare programs globally. The Ozempic procurement reflects the company's role as a critical vendor in the federal pharmaceutical supply chain for diabetes management and related therapeutic needs within the Defense Health Agency and broader military healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F7VA3?
SPE2DR26F7VA3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F7VA3 worth?
The government has obligated $16,669 on SPE2DR26F7VA3.
Is contract SPE2DR26F7VA3 an order under another contract?
Yes. SPE2DR26F7VA3 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7VA3 competed?
The extent of competition for SPE2DR26F7VA3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award